|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Agenda Items
|
||||||||||||||||||||||
|
1 - Opening, moment of silence, performing of the national anthem and appointment of the Chairman of the Meeting.
|
||||||||||||||||||||||
|
2 - Review and discussion of the Annual Report for fiscal year 2024 as prepared by the Board of Directors.
|
||||||||||||||||||||||
|
3 - Presentation of the report of the independent auditing firm for fiscal year 2024.
|
||||||||||||||||||||||
|
4 - Review, discussion and approval of financial statements for fiscal year 2024.
|
||||||||||||||||||||||
|
5 - Reaching resolution on the acquittal of the members of Board of Directors on operations and accounts of the company for fiscal year 2024.
|
||||||||||||||||||||||
|
6 - Determination of the dividend distribution and the dividend payout ratio for fiscal year 2024.
|
||||||||||||||||||||||
|
7 - Election of members of the Board of Directors, including independent members of the Board of Directors, and determination of their terms of office.
|
||||||||||||||||||||||
|
8 - Determination of the remuneration of the members of the Board of Directors.
|
||||||||||||||||||||||
|
9 - Election of the independent audit company in accordance with the Turkish Commercial Code numbered 6102 and Capital Market Law numbered 6362 and other relevant legislation.
|
||||||||||||||||||||||
|
10 - Submitting information on donations made; guarantee, pledge, mortgage and warranties given on behalf of third parties and revenue and benefits acquired in 2024.
|
||||||||||||||||||||||
|
11 - Providing information regarding the reports, which comprises the conditions of the transactions with Presidency of Defense Industries and its comparison with the market conditions in 2024, as per the regulations of the Capital Markets Board.
|
||||||||||||||||||||||
|
12 - Determining the upper limit of donations and aids to be made in fiscal year 2025.
|
||||||||||||||||||||||
|
13 - Determining the upper limit of sponsorships to be made in fiscal year 2025.
|
||||||||||||||||||||||
|
14 - Submitting information on the subject that shareholders who got the administrative competence, members of board of directors, managers with administrative liability and their spouses, relatives by blood or marriage up to second degree may conduct a transaction with the corporation or subsidiaries thereof which may cause a conflict of interest and compete with them.
|
||||||||||||||||||||||
|
15 - Wishes and recommendations.
|
||||||||||||||||||||||
|
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
The informative document related to the 50th Ordinary General Assembly Meeting, where our Company's 2024 activities shall be discussed, including the agenda, explanations about the agenda items, power of attorney template and the reports of related party transactions on 2024, which were prepared as per the Communiqué on Corporate Governance numbered II-17.1 of Capital Market Board, is attached. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail. |